← Browse by Condition
Medical Condition
small lymphocytic lymphoma
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 3
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Enrollment
614 pts
Location
United States, Austr...
Sponsor
BeOne Medicines
NCT05031897 Phase 2
Recruiting
Two Step Haplo With Radiation Conditioning
Enrollment
63 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT05805605 Phase 2
Recruiting
Allo HSCT Using RIC and PTCy for Hematological Diseases
Enrollment
56 pts
Location
United States
Sponsor
Masonic Cancer Center, Univers...
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Enrollment
700 pts
Location
United States, Argen...
Sponsor
Janssen Research & Development...
NCT04560322 Phase 2
Recruiting
Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
Enrollment
40 pts
Location
United States
Sponsor
Massachusetts General Hospital